Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IHS | News: IHS Interpose Holdings Changes Name; Appoints MD | 21/06/18 | 0 | 1.7K | |||
|
|||||||
IHS | Ann: Results of Shareholder General Meeting | 15/06/18 | 1 | 2.1K | |||
|
|||||||
IHS | Ann: Zimbabwe In Country Approvals Received | 15/06/18 | 3 | 4.0K | |||
|
|||||||
IHS | News: IHS Interpose Gets Approval For Acquisition Of TCF Plus Potential Gas-Condesate Project | 15/06/18 | 0 | 564 | |||
|
|||||||
IHS | Super giant structure | 14/06/18 | 10 | 7.2K | |||
|
|||||||
IHS | Ann: Notice of Extraordinary General Meeting/Proxy Form | 15/05/18 | 0 | 853 | |||
|
|||||||
IHS | Anyone got a summary on the company | 30/04/18 | 0 | 776 | |||
|
|||||||
IHS | Ann: Quarterly Report March 2018 | 27/04/18 | 0 | 1.3K | |||
|
See All Discussions